There were significant differences in the distribution of histologic subtype and race between the 2 ANO6 expressers (P < .001), but age, gender, menopause status, and cancer stage in the low ANO6 group were not significantly different from those in the high ANO6 group (P > .05) (Table 1). Here, ANO6 is linked to cancer.